The Week

Rocket Lab (RKLB) fell 2.04% this week to close at $62.95, while the S&P 500 slipped 0.8%, leaving the stock about 1.24 percentage points behind the benchmark. The week saw a wide 9.45% trading range across just four sessions, with an early push followed by a pullback: Tuesday opened at $65.27 and briefly touched $67.48, but the next three days drifted lower, hitting an intraday low of $61.53 on Thursday before a modest rebound to $62.95 on Friday. The 20-day and 60-day moving averages sit at $68.38 and $76.27 respectively, so the stock remains below both. Average daily volume came in at roughly 21.3 million shares, about 13.8% above the 60-day median.\n\n## Key Events

Two company-specific stories anchored the week. On 8 September, Rocket Lab introduced its IMM Apex solar cell with 31.5% efficiency for space applications, aimed at reducing reliance on supply-constrained critical minerals. The news lifted after-hours and pre-market trading, with overnight gains exceeding 3% at one point. On 11 September, the company completed its 16th Electron mission of the year, reinforcing its position as a leading small launch provider; shares rose as much as 1.67% intraday and held firmer in subsequent sessions. Across the sector, Stoke Space raised $1 billion to develop a larger reusable rocket, while space stocks traded mixed through the week. Some peers such as VCX dropped sharply mid-week, while RKLB held up relatively well from Thursday onward. Cathie Wood’s reported buying and the company’s $8 billion bet related to Iridium also surfaced in weekend coverage, leaving a thread for next week.\n\n## Analyst Ratings

Among 21 institutions covering Rocket Lab, 12 rate it buy, 4 rate it overweight, 4 rate it hold, and 1 has no opinion, with no sell or underweight ratings. The consensus recommendation is buy, and the consensus target price of $109.37 sits about 73.7% above the latest close of $62.95. The target range is wide: the lowest target is $64 and the highest is $150, more than a two-to-one spread, suggesting meaningful disagreement on the growth path. Within the aerospace and defence industry, Rocket Lab ranks 11th out of 84 names. Raymond James initiated coverage on 11 September with an outperform rating and a $80 target, the latest first take this week.\n\n## The Week Ahead

The US macro calendar dominates next week. On 15 September, the New York Fed manufacturing index is due, with the prior at 20.6 and expectations around 14.75. On 16 September, retail sales, retail sales ex-autos, retail control, import prices, the NAHB housing market index, and EIA weekly crude inventories all land on the same day. Retail sales came in at -0.6 previously, against a consensus forecast of 0.9, so a weak print could add pressure on risk appetite. RKLB has no earnings window disclosed, but the sector’s mixed momentum this week and any follow-through on the Iridium-related story could get repriced as the macro data drops.\n\n## In Short

RKLB lagged the market this week despite a fundamentally active stretch: the new solar cell and the 16th Electron launch both point to continued operational momentum. On the other side of the ledger, valuation remains elevated at around 10.8x price-to-book, and while the consensus target sits well above spot, the gap between the lowest and highest targets shows expectations have not converged. The latest session’s flow snapshot shows large and medium orders as net sellers while small orders were net buyers, a divergence between institutions and retail. The key question for the coming days is whether the US retail data can steady risk appetite and whether the rotation within the space complex deepens.\n\nThis article is generated by LongbridgeAI from market data, for information only and not investment advice.\n